In Reply:

This publication has 11 references indexed in Scilit:

• Indium-111–Capromab Pendetide Radioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men After Failed Prostatectomy
  Journal of Clinical Oncology, 2003
• A positron-emitting internal marker for identification of normal tissue by positron emission tomography: phantom studies and validation in patients.
  Molecular Imaging & Biology, 2003
• In response to Drs. Kagan and Schulz
  International Journal of Radiation Oncology*Biology*Physics, 2003
• A commentary on dose escalation and bNED in prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer
  Urology, 2000
• Critical Thinking
  American Journal of Roentgenology, 2000
• IN-111 CAPROMAB PENDETIDE MAB SCAN PREDICTS RESPONSE TO RADIOTHERAPY TO THE PROSTATE FOSSA IN MEN WITH TUMOR RECURRENCE FOLLOWING RADICAL PROSTATECTOMY
  Journal of Urology, 1999
• Radiolabeled Monoclonal Antibody Indium 111-Labeled CYT-356 Localizes Extraprostatic Recurrent Carcinoma After Prostatectomy
  Urology, 1998
• Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.
  Journal of Clinical Oncology, 1998
• State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy
  International Journal of Radiation Oncology*Biology*Physics, 1997